PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY : DR SAI CNR (5060021493),SAI CNR POLYCLINIC AND
TEST ASKED : AAROGYAM CAMP PROFILE 2 DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI HIGH
SCHOOL, JPN ROAD, YELLAM BAZAR, WARANGAL,
Summary Report
Tests outside reference range
TEST NAME OBSERVED VALUE UNITS Bio. Ref. Interval.
CARDIAC RISK MARKERS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) 5.69 mg/L <3
LIPOPROTEIN (A) [LP(A)] 62.5 mg/dL < 30
COMPLETE HEMOGRAM
MEAN CORP.HEMO.CONC(MCHC) 31 g/dL 31.5-34.5
PLATELETCRIT(PCT) 0.18 % 0.19-0.39
DIABETES
AVERAGE BLOOD GLUCOSE (ABG) 163 mg/dL 90-120
HbA1c 7.3 % < 5.7
LIPID
HDL / LDL RATIO 0.38 Ratio > 0.40
HDL CHOLESTEROL - DIRECT 38 mg/dL 40-60
LDL CHOLESTEROL - DIRECT 101 mg/dL < 100
TRIG / HDL RATIO 4.48 Ratio < 3.12
TRIGLYCERIDES 171 mg/dL < 150
RENAL
EST. GLOMERULAR FILTRATION RATE (eGFR) 83 mL/min/1.73 m2 >= 90
THYROID
TSH - ULTRASENSITIVE 5.51 µIU/mL 0.54-5.30
VITAMINS
25-OH VITAMIN D (TOTAL) 18.1 ng/mL 30-100
Disclaimer: The above listed is the summary of the parameters with values outside the BRI. For detailed report values,
parameter correlation and clinical interpretation, kindly refer to the same in subsequent pages.
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY (5060021493),SAI CNR POLYCLINIC AND
: DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP
TEST ASKED : HBA PROFILE,HEMOGRAM RISHI HIGH SCHOOL, JPN ROAD, YELLAM BAZAR,
WARANGAL, INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS
HbA1c - (HPLC)
H.P.L.C 7.3 %
Bio. Ref. Interval. :
Bio. Ref. Interval.: As per ADA Guidelines Guidance For Known Diabetics
Below 5.7% : Normal Below 6.5% : Good Control
5.7% - 6.4% : Prediabetic 6.5% - 7% : Fair Control
>=6.5% : Diabetic 7.0% - 8% : Unsatisfactory Control
>8% : Poor Control
Method : Fully Automated H.P.L.C method
AVERAGE BLOOD GLUCOSE (ABG) CALCULATED 163 mg/dL
Bio. Ref. Interval. :
90 - 120 mg/dl : Good Control
121 - 150 mg/dl : Fair Control
151 - 180 mg/dl : Unsatisfactory Control
> 180 mg/dl : Poor Control
Method : Derived from HBA1c values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 03:42
Sample Type : EDTA Whole Blood
Labcode : 0707109010/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CE070472
Page : 1 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY : DR SAI CNR (5060021493),SAI CNR POLYCLINIC AND
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP
TEST ASKED : HBA PROFILE,HEMOGRAM
RISHI HIGH SCHOOL, JPN ROAD, YELLAM
BAZAR, WARANGAL, INDIA,506002
TEST NAME METHODOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL LEUCOCYTES COUNT (WBC) HF & FC 5.02 X 10³ / µL 4.0 - 10.0
NEUTROPHILS Flow Cytometry 59.6 % 40-80
LYMPHOCYTE Flow Cytometry 28.5 % 20-40
MONOCYTES Flow Cytometry 5.8 % 2-10
EOSINOPHILS Flow Cytometry 5 % 1-6
BASOPHILS Flow Cytometry 0.8 % 0-2
IMMATURE GRANULOCYTE PERCENTAGE(IG%) Flow Cytometry 0.3 % 0-0.5
NEUTROPHILS - ABSOLUTE COUNT Calculated 2.99 X 10³ / µL 2.0-7.0
LYMPHOCYTES - ABSOLUTE COUNT Calculated 1.43 X 10³ / µL 1.0-3.0
MONOCYTES - ABSOLUTE COUNT Calculated 0.29 X 10³ / µL 0.2 - 1.0
BASOPHILS - ABSOLUTE COUNT Calculated 0.04 X 10³ / µL 0.02 - 0.1
EOSINOPHILS - ABSOLUTE COUNT Calculated 0.25 X 10³ / µL 0.02 - 0.5
IMMATURE GRANULOCYTES(IG) Calculated 0.02 X 10³ / µL 0-0.3
TOTAL RBC HF & EI 4.87 X 10^6/µL 4.5-5.5
NUCLEATED RED BLOOD CELLS Calculated 0.01 X 10³ / µL 0.0-0.5
NUCLEATED RED BLOOD CELLS % Flow Cytometry 0.01 % 0.0-5.0
HEMOGLOBIN SLS-Hemoglobin Method 13.2 g/dL 13.0-17.0
HEMATOCRIT(PCV) CPH Detection 42.6 % 40.0-50.0
MEAN CORPUSCULAR VOLUME(MCV) Calculated 87.5 fL 83.0-101.0
MEAN CORPUSCULAR HEMOGLOBIN(MCH) Calculated 27.1 pq 27.0-32.0
MEAN CORP.HEMO.CONC(MCHC) Calculated 31 g/dL 31.5-34.5
RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) Calculated 44.5 fL 39-46
RED CELL DISTRIBUTION WIDTH (RDW-CV) Calculated 14 % 11.6-14
PLATELET DISTRIBUTION WIDTH(PDW) Calculated 11.3 fL 9.6-15.2
MEAN PLATELET VOLUME(MPV) Calculated 9.8 fL 6.5-12
PLATELET COUNT HF & EI 183 X 10³ / µL 150-410
PLATELET TO LARGE CELL RATIO(PLCR) Calculated 23.9 % 19.7-42.4
PLATELETCRIT(PCT) Calculated 0.18 % 0.19-0.39
Remarks : Alert!!! Predominantly normocytic normochromic with ovalocytes. Platelets:Appear adequate in smear.
Clinical history is asked for all the relevant abnormalities detected and in absence / failure of receiving of clinical history,
results are rechecked twice and released. Advised clinical correlation.
Method : Fully automated bidirectional analyser (6 Part Differential SYSMEX XN-1000)
(Reference : *FC- flowcytometry, *HF- hydrodynamic focussing, *EI- Electric Impedence, *Hb- hemoglobin, *CPH- Cumulative pulse height)
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 03:42
Sample Type : EDTA Whole Blood
Labcode : 0707109010/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CE070472 Page : 2 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY (5060021493),SAI CNR POLYCLINIC AND
: DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP
TEST ASKED : AAROGYAM CAMP PROFILE 2 RISHI HIGH SCHOOL, JPN ROAD, YELLAM BAZAR,
WARANGAL, INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS
25-OH VITAMIN D (TOTAL) E.C.L.I.A 18.1 ng/mL
Bio. Ref. Interval. :
Deficiency : <=20 ng/ml || Insufficiency : 21-29 ng/ml
Sufficiency : >= 30 ng/ml || Toxicity : >100 ng/ml
Clinical Significance:
Vitamin D is a fat soluble vitamin that has been known to help the body absorb and retain calcium and phosphorous; both are critical
for building bone health.
Decrease in vitamin D total levels indicate inadequate exposure of sunlight, dietary deficiency, nephrotic syndrome.
Increase in vitamin D total levels indicate Vitamin D intoxication.
Specifications: Precision: Intra assay (%CV):9.20%, Inter assay (%CV):8.50%
Kit Validation Reference : Holick M. Vtamin D the underappreciated D-Lightful hormone that is important for Skeletal
and cellular health Curr Opin Endocrinol Diabetes 2002:9(1)87-98.
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
VITAMIN B-12 E.C.L.I.A 267 pg/mL
Bio. Ref. Interval. :
Normal: 197-771 pg/ml
Clinical significance :
Vitamin B12 or cyanocobalamin, is a complex corrinoid compound found exclusively from animal dietary sources, such as meat, eggs
and milk. It is critical in normal DNA synthesis, which in turn affects erythrocyte maturation and in the formation of myelin sheath.
Vitamin-B12 is used to find out neurological abnormalities and impaired DNA synthesis associated with macrocytic anemias. For
diagnostic purpose, results should always be assessed in conjunction with the patients medical history, clinical examination and
other findings.
Specifications: Intra assay (%CV):2.6%, Inter assay (%CV):2.3 %
Kit Validation Reference : Thomas L.Clinical laborator Diagnostics : Use and Assessment of Clinical laboratory Results 1st Edition,TH
Books-Verl-Ges,1998:424-431
Method : Fully Automated Electrochemiluminescence Compititive Immunoassay
Please correlate with clinical conditions.
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Labcode : 0707109012/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CO790930
Page : 3 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY (5060021493),SAI CNR POLYCLINIC AND
: DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP
TEST ASKED : AAROGYAM CAMP PROFILE 2 RISHI HIGH SCHOOL, JPN ROAD, YELLAM BAZAR,
WARANGAL, INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS
APOLIPOPROTEIN - A1 (APO-A1) IMMUNOTURBIDIMETRY 137 mg/dL
Bio. Ref. Interval. :
Male : 86 - 152
Female : 94 - 162
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APOLIPOPROTEIN - B (APO-B) IMMUNOTURBIDIMETRY 97 mg/dL
Bio. Ref. Interval. :
Male : 56 - 145
Female : 53 - 138
Method : FULLY AUTOMATED RATE IMMUNOTURBIDIMETRY – BECKMAN COULTER
APO B / APO A1 RATIO (APO B/A1) CALCULATED 0.7 Ratio
Bio. Ref. Interval. :
Male : 0.40 - 1.26
Female : 0.38 - 1.14
Method : Derived from serum Apo A1 and Apo B values
Please correlate with clinical conditions.
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Labcode : 0707109012/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CO790930
Page : 4 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY : DR SAI CNR (5060021493),SAI CNR POLYCLINIC AND
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI
TEST ASKED : AAROGYAM CAMP PROFILE 2
HIGH SCHOOL, JPN ROAD, YELLAM BAZAR,
WARANGAL, INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS
HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP) IMMUNOTURBIDIMETRY 5.69 mg/L
Bio. Ref. Interval. :-
< 1.00 - Low Risk
1.00 - 3.00 - Average Risk
>3.00 - 10.00 - High Risk
> 10.00 - Possibly due to Non-Cardiac Inflammation
Disclaimer: Persistent unexplained elevation of HSCRP >10 should be evaluated for non-cardiovascular etiologies such as
infection , active arthritis or concurrent illness.
Clinical significance:
High sensitivity C- reactive Protein ( HSCRP) can be used as an independent risk marker for the identification of Individuals at risk
for future cardiovascular Disease. A coronary artery disease risk assessment should be based on the average of two hs-CRP
tests, ideally taken two weeks apart.
Kit Validation Reference:
1.Clinical management of laboratory date in medical practice 2003-3004, 207(2003).
2.Tietz : Textbook of Clinical Chemistry and Molecular diagnostics :Second edition :Chapter 47:Page no.1507- 1508.
Please correlate with clinical conditions.
Method:- FULLY AUTOMATED LATEX AGGLUTINATION – BECKMAN COULTER
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Dr Amulya MD (Path) Dr Ramya MD (Path)
Labcode : 0707109012/TE052
Barcode : CO790930 Page : 5 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY : DR SAI CNR (5060021493),SAI CNR POLYCLINIC AND
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI
TEST ASKED : AAROGYAM CAMP PROFILE 2
HIGH SCHOOL, JPN ROAD, YELLAM BAZAR,
WARANGAL, INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS
LIPOPROTEIN (A) [LP(A)] IMMUNOTURBIDIMETRY 62.5 mg/dL
Bio. Ref. Interval. :-
Adults : < 30.0 mg/dl
Clinical Significance:
Determination of LPA may be useful to guide management of individuals with a family history of CHD or with existing disease. The
levels of LPA in the blood depends on genetic factors; The range of variation in a population is relatively large and hence for
diagnostic purpose, results should always be assessed in conjunction with the patient’s medical history, clinical examination and
other findings.
Specifications:
Precision %CV :- Intra assay %CV- 4.55% , Inter assay %CV-0.86 %
Kit Validation Reference:
Tietz NW,Clinical Guide to Laboratory Tests Philadelphia WB. Saunders 1995 : 442-444
Please correlate with clinical conditions.
Method:- LATEX ENHANCED IMMUNOTURBIDIMETRY
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Dr Amulya MD (Path) Dr Ramya MD (Path)
Labcode : 0707109012/TE052
Barcode : CO790930 Page : 6 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY (5060021493),SAI CNR POLYCLINIC AND
: DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI HIGH
TEST ASKED : AAROGYAM CAMP PROFILE 2 SCHOOL, JPN ROAD, YELLAM BAZAR, WARANGAL,
INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL CHOLESTEROL PHOTOMETRY 170 mg/dL < 200
HDL CHOLESTEROL - DIRECT PHOTOMETRY 38 mg/dL 40-60
LDL CHOLESTEROL - DIRECT PHOTOMETRY 101 mg/dL < 100
TRIGLYCERIDES PHOTOMETRY 171 mg/dL < 150
TC/ HDL CHOLESTEROL RATIO CALCULATED 4.5 Ratio 3-5
TRIG / HDL RATIO CALCULATED 4.48 Ratio < 3.12
LDL / HDL RATIO CALCULATED 2.6 Ratio 1.5-3.5
HDL / LDL RATIO CALCULATED 0.38 Ratio > 0.40
NON-HDL CHOLESTEROL CALCULATED 132.1 mg/dL < 160
VLDL CHOLESTEROL CALCULATED 34.22 mg/dL 5 - 40
Please correlate with clinical conditions.
Method :
CHOL - Cholesterol Oxidase, Esterase, Peroxidase
HCHO - Direct Enzymatic Colorimetric
LDL - Direct Measure
TRIG - Enzymatic, End Point
TC/H - Derived from serum Cholesterol and Hdl values
TRI/H - Derived from TRIG and HDL Values
LDL/ - Derived from serum HDL and LDL Values
HD/LD - Derived from HDL and LDL values.
NHDL - Derived from serum Cholesterol and HDL values
VLDL - Derived from serum Triglyceride values
*REFERENCE RANGES AS PER NCEP ATP III GUIDELINES:
TOTAL CHOLESTEROL (mg/dl) HDL (mg/dl) LDL (mg/dl) TRIGLYCERIDES (mg/dl)
DESIRABLE <200 LOW <40 OPTIMAL <100 NORMAL <150
BORDERLINE HIGH 200-239 HIGH >60 NEAR OPTIMAL 100-129 BORDERLINE HIGH 150-199
BORDERLINE HIGH
HIGH >240 130-159 HIGH 200-499
HIGH 160-189 VERY HIGH >500
VERY HIGH >190
Alert !!! 10-12 hours fasting is mandatory for lipid parameters. If not, values might fluctuate.
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Labcode : 0707109012/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CO790930 Page : 7 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY (5060021493),SAI CNR POLYCLINIC AND
: DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI HIGH
TEST ASKED : AAROGYAM CAMP PROFILE 2 SCHOOL, JPN ROAD, YELLAM BAZAR, WARANGAL,
INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
ALKALINE PHOSPHATASE PHOTOMETRY 59.53 U/L 45-129
BILIRUBIN - TOTAL PHOTOMETRY 0.43 mg/dL 0.3-1.2
BILIRUBIN -DIRECT PHOTOMETRY 0.06 mg/dL < 0.3
BILIRUBIN (INDIRECT) CALCULATED 0.37 mg/dL 0-0.9
GAMMA GLUTAMYL TRANSFERASE (GGT) PHOTOMETRY 24.21 U/L < 55
ASPARTATE AMINOTRANSFERASE (SGOT ) PHOTOMETRY 22.26 U/L < 35
ALANINE TRANSAMINASE (SGPT) PHOTOMETRY 17.52 U/L < 45
SGOT / SGPT RATIO CALCULATED 1.27 Ratio <2
PROTEIN - TOTAL PHOTOMETRY 7.29 gm/dL 5.7-8.2
ALBUMIN - SERUM PHOTOMETRY 4.32 gm/dL 3.2-4.8
SERUM GLOBULIN CALCULATED 2.97 gm/dL 2.5-3.4
SERUM ALB/GLOBULIN RATIO CALCULATED 1.45 Ratio 0.9 - 2
Please correlate with clinical conditions.
Method :
ALKP - Modified IFCC method
BILT - Vanadate Oxidation
BILD - Vanadate Oxidation
BILI - Derived from serum Total and Direct Bilirubin values
GGT - Modified IFCC method
SGOT - IFCC* Without Pyridoxal Phosphate Activation
SGPT - IFCC* Without Pyridoxal Phosphate Activation
OT/PT - Derived from SGOT and SGPT values.
PROT - Biuret Method
SALB - Albumin Bcg¹method (Colorimetric Assay Endpoint)
SEGB - DERIVED FROM SERUM ALBUMIN AND PROTEIN VALUES
A/GR - Derived from serum Albumin and Protein values
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Labcode : 0707109012/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CO790930 Page : 8 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY (5060021493),SAI CNR POLYCLINIC AND
: DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI HIGH
TEST ASKED : AAROGYAM CAMP PROFILE 2 SCHOOL, JPN ROAD, YELLAM BAZAR, WARANGAL,
INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
BLOOD UREA NITROGEN (BUN) PHOTOMETRY 15.04 mg/dL 7.94 - 20.07
CREATININE - SERUM PHOTOMETRY 1 mg/dL 0.72-1.18
BUN / SR.CREATININE RATIO CALCULATED 15.04 Ratio 9:1-23:1
UREA (CALCULATED) CALCULATED 32.19 mg/dL Adult : 17-43
UREA / SR.CREATININE RATIO CALCULATED 32.19 Ratio < 52
CALCIUM PHOTOMETRY 9.32 mg/dL 8.8-10.6
URIC ACID PHOTOMETRY 6.8 mg/dL 4.2 - 7.3
Please correlate with clinical conditions.
Method :
BUN - Kinetic UV Assay.
SCRE - Creatinine Enzymatic Method
B/CR - Derived from serum Bun and Creatinine values
UREAC - Derived from BUN Value.
UR/CR - Derived from UREA and Sr.Creatinine values.
CALC - Arsenazo III Method, End Point.
URIC - Uricase / Peroxidase Method
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Labcode : 0707109012/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CO790930 Page : 9 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
(5060021493),SAI CNR POLYCLINIC AND
REF. BY : DR SAI CNR
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI HIGH
TEST ASKED : AAROGYAM CAMP PROFILE 2 SCHOOL, JPN ROAD, YELLAM BAZAR, WARANGAL,
INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS Bio. Ref. Interval.
TOTAL TRIIODOTHYRONINE (T3) E.C.L.I.A 122 ng/dL 80-200
TOTAL THYROXINE (T4) E.C.L.I.A 9.83 µg/dL 4.8-12.7
TSH - ULTRASENSITIVE E.C.L.I.A 5.51 µIU/mL 0.54-5.30
Comments : ***
The Biological Reference Ranges is specific to the age group. Kindly correlate clinically.
Method :
T3,T4 - Fully Automated Electrochemiluminescence Compititive Immunoassay
USTSH - Fully Automated Electrochemiluminescence Sandwich Immunoassay
Disclaimer :Results should always be interpreted using the reference range provided by the laboratory that
performed the test. Different laboratories do tests using different technologies, methods and using different
reagents which may cause difference. In reference ranges and hence it is recommended to interpret result with
assay specific reference ranges provided in the reports. To diagnose and monitor therapy doses, it is recommended
to get tested every time at the same Laboratory.
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Labcode : 0707109012/TE052 Dr Amulya MD (Path) Dr Ramya MD (Path)
Barcode : CO790930 Page : 10 of 12
PROCESSED AT :
Thyrocare
H. NO. 1-9-645,Vidyanagar,
Adikmet Road,Near SBH,
Hyderabad-500 044
NAME : N SURENDER (58Y/M) SAMPLE COLLECTED AT :
REF. BY : DR SAI CNR (5060021493),SAI CNR POLYCLINIC AND
DIAGNOSTICS,MOGILAIAH HALL LANE, OPP RISHI
TEST ASKED : AAROGYAM CAMP PROFILE 2
HIGH SCHOOL, JPN ROAD, YELLAM BAZAR,
WARANGAL, INDIA,506002
TEST NAME TECHNOLOGY VALUE UNITS
EST. GLOMERULAR FILTRATION RATE (eGFR) CALCULATED 83 mL/min/1.73 m2
Bio. Ref. Interval. :-
> = 90 : Normal
60 - 89 : Mild Decrease
45 - 59 : Mild to Moderate Decrease
30 - 44 : Moderate to Severe Decrease
15 - 29 : Severe Decrease
Clinical Significance
The normal serum creatinine reference interval does not necessarily reflect a normal GFR for a patient. Because mild and
moderate kidney injury is poorly inferred from serum creatinine alone. Thus, it is recommended for clinical laboratories to routinely
estimate glomerular filtration rate (eGFR), a “gold standard” measurement for assessment of renal function, and report the value
when serum creatinine is measured for patients 18 and older, when appropriate and feasible. It cannot be measured easily in
clinical practice, instead, GFR is estimated from equations using serum creatinine, age, race and sex. This provides easy to
interpret information for the doctor and patient on the degree of renal impairment since it approximately equates to the
percentage of kidney function remaining. Application of CKD-EPI equation together with the other diagnostic tools in renal
medicine will further improve the detection and management of patients with CKD.
Reference
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration
rate. Ann Intern Med. 2009;150(9):604-12.
Please correlate with clinical conditions.
Method:- CKD-EPI Creatinine Equation
~~ End of report ~~
Sample Collected on (SCT) : 07 Jul 2024 07:20
Sample Received on (SRT) : 08 Jul 2024 01:03
Report Released on (RRT) : 08 Jul 2024 05:55
Sample Type : SERUM
Dr Amulya MD (Path) Dr Ramya MD (Path)
Labcode : 0707109012/TE052
Barcode : CO790930 Page : 11 of 12
CONDITIONS OF REPORTING
v The reported results are for information and interpretation of the referring doctor only.
v It is presumed that the tests performed on the specimen belong to the patient; named or identified.
v Results of tests may vary from laboratory to laboratory and also in some parameters from time to time for the same
patient.
v Should the results indicate an unexpected abnormality, the same should be reconfirmed.
v Only such medical professionals who understand reporting units, reference ranges and limitations of technologies
should interpret results.
v This report is not valid for medico-legal purpose.
v Neither Thyrocare, nor its employees/representatives assume any liability, responsibility for any loss or damage that
may be incurred by any person as a result of presuming the meaning or contents of the report.
v Thyrocare Discovery video link :- https://youtu.be/nbdYeRgYyQc
v For clinical support please contact @8450950852,8450950853,8450950854 between 10:00 to 18:00
EXPLANATIONS
v Majority of the specimen processed in the laboratory are collected by Pathologists and Hospitals we call them
as "Clients".
v Name - The name is as declared by the client and recored by the personnel who collected the specimen.
v Ref.Dr - The name of the doctor who has recommended testing as declared by the client.
v Labcode - This is the accession number in our laboratory and it helps us in archiving and retrieving the data.
v Barcode - This is the specimen identity number and it states that the results are for the specimen bearing
the barcode (irrespective of the name).
v SCP - Specimen Collection Point - This is the location where the blood or specimen was collected as declared by
the client.
v SCT - Specimen Collection Time - The time when specimen was collected as declared by the client.
v SRT - Specimen Receiving Time - This time when the specimen reached our laboratory.
v RRT - Report Releasing Time - The time when our pathologist has released the values for Reporting.
v Reference Range - Means the range of values in which 95% of the normal population would fall.
SUGGESTIONS
v Values out of reference range requires reconfirmation before starting any medical treatment.
v Retesting is needed if you suspect any quality shortcomings.
v Testing or retesting should be done in accredited laboratories.
v For suggestions, complaints or feedback, write to us at info@thyrocare.com or call us on
022-3090 0000 / 6712 3400
v SMS:<Labcode No.> to 9870666333
+T&C Apply, # Upto 95% Samples in NABL Accredited Labs, * As per a survey on doctors' perception of laboratory diagnostics (IJARIIT,2023)
Page : 12 of 12
